Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Anti-CD38 monoclonal antibody & Multiple Myeloma (MM) / Plasmocytoma

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Anti-CD38 (Cyclic ADP Ribose Hydrolase) monoclonal antibodies naked monoclonal antibodies have become the standard of care in Multiple Myeloma (MM) / Plasmocytoma and significantly improve the depth and duration of response when combined with conventional therapy.
Jullien et al. 2021 Expert Review of Anticancer Therapy 21: 33-43

…

Anti CD38 monoclonal antibodies for multiple myeloma treatment.
Gozzetti et al. 2022 Hum Vaccin Immunother 18(5): 2052658
Review
CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance
van de Donk & Usmani 2018 Front Immunol 9: 2134
Review
Monoclonal antibodies as an addition to current myeloma therapy strategies
Jullien et al. 2021 Expert Review of Anticancer Therapy 21: 33-43
Review

7/1/2026